Free Trial

TCW Group Inc. Invests $5.10 Million in Grail, Inc. (NASDAQ:GRAL)

Grail logo with Medical background

TCW Group Inc. acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 285,435 shares of the company's stock, valued at approximately $5,095,000. TCW Group Inc. owned approximately 0.85% of Grail at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. abrdn plc acquired a new position in Grail during the fourth quarter worth about $3,768,000. Douglas Lane & Associates LLC purchased a new position in Grail in the 4th quarter worth approximately $3,034,000. Slow Capital Inc. purchased a new position in Grail in the 4th quarter worth approximately $2,379,000. 180 Wealth Advisors LLC acquired a new position in shares of Grail during the 4th quarter worth approximately $1,681,000. Finally, Moloney Securities Asset Management LLC purchased a new stake in shares of Grail in the fourth quarter valued at approximately $559,000.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on GRAL shares. Morgan Stanley started coverage on Grail in a research note on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price objective on the stock. Wolfe Research assumed coverage on shares of Grail in a research report on Friday, November 15th. They set a "peer perform" rating on the stock.

Read Our Latest Research Report on GRAL

Grail Stock Down 5.9 %

Shares of NASDAQ GRAL traded down $2.65 during midday trading on Tuesday, reaching $42.65. 1,496,640 shares of the stock were exchanged, compared to its average volume of 1,515,163. The company has a 50 day simple moving average of $27.15 and a 200 day simple moving average of $19.44. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. On average, equities research analysts predict that Grail, Inc. will post -15.15 earnings per share for the current year.

Grail Company Profile

(Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Featured Articles

Institutional Ownership by Quarter for Grail (NASDAQ:GRAL)

Should You Invest $1,000 in Grail Right Now?

Before you consider Grail, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.

While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These Are the 3 Stocks Most Likely to SPLIT in 2025
NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines